Literature DB >> 1677886

Drug treatment of hypertension in patients with diabetes mellitus.

P P Stein1, H R Black.   

Abstract

Patients with diabetes mellitus have an increased prevalence of hypertension and its vascular consequences, including coronary and cerebrovascular disease. Drug treatment of hypertension in diabetic subjects is fraught with potential difficulties, including the altered efficacy of medications, the increased risk of side effects, and the possibility of worsening glycemic control and increasing serum lipid levels. Despite these difficulties, treatment is an important part of reducing morbidity and mortality from vascular events. Antihypertensive therapy may also have the potential to prevent or retard the development of diabetic nephropathy. In this article, we discuss the efficacy and metabolic and nonmetabolic side effects of the various classes of antihypertensive agents in patients with diabetes mellitus and suggest a stepped-care approach to the drug treatment of patients with hypertension and diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677886     DOI: 10.2337/diacare.14.6.425

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  17 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Management of hypertension in overweight and obese patients: a practical guide for clinicians.

Authors:  Francesco Dentali; Arya M Sharma; James D Douketis
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

Authors:  G Piédrola; E Novo; J Serrano-Gotarredona; M L de Teresa; R García-Robles
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

Review 5.  Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

Authors:  K G Dawson; J K McKenzie; S A Ross; J L Chiasson; P Hamet
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

Review 6.  Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.

Authors:  R Donnelly; A D Morris
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

7.  Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans.

Authors:  M Uehara; H Kishikawa; S Isami; K Kisanuki; Y Ohkubo; N Miyamura; T Miyata; T Yano; M Shichiri
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 8.  The management of hypertension in the overweight and obese patient: is weight reduction sufficient?

Authors:  James D Douketis; Arya M Sharma
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Description and quality assessment.

Authors:  G Van den Brink; R R Schwartzenberg; L J Hoeve; A J Porsius; L L Hoeve
Journal:  Pharm World Sci       Date:  1993-06-18

Review 10.  Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

Authors:  C J Dunn; C M Spencer
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.